Related Experiment Video

Updated: Oct 13, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.1K

Approach to Pediatric Obesity and Nonalcoholic Fatty Liver Disease

Johanna M Ascher Bartlett, Naveen Mittal

    Pediatric Annals
    |November 10, 2021
    PubMed

    Insights

    Pediatric nonalcoholic fatty liver disease (NAFLD) is rising with childhood obesity. Early diagnosis and management are crucial to prevent serious liver complications in children.

    Area of Science:

    • Pediatric Gastroenterology
    • Hepatology
    • Public Health

    Background:

    • Childhood obesity is a growing epidemic, leading to complex health challenges.
    • Pediatric nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in children, strongly linked to obesity.
    • Untreated NAFLD can result in severe long-term complications such as cirrhosis and liver cancer.

    Purpose of the Study:

    • To provide an overview of pediatric nonalcoholic fatty liver disease (NAFLD).
    • To discuss updated diagnostic and management strategies for pediatric NAFLD.
    • To emphasize the pediatrician's role in addressing this condition.

    Main Methods:

    • Literature review of current research on pediatric NAFLD.
    • Analysis of updated diagnostic criteria and clinical guidelines.
    • Discussion of therapeutic interventions and management protocols.

    Main Results:

    • NAFLD prevalence is increasing significantly in pediatric populations.
    • Early identification and intervention are critical for improving outcomes.
    • Multidisciplinary approaches are often necessary for effective management.

    Conclusions:

    • Pediatric NAFLD requires prompt attention due to its increasing prevalence and potential for severe sequelae.
    • Pediatricians play a vital role in the diagnosis, management, and prevention of pediatric NAFLD.
    • Adherence to updated guidelines is essential for optimizing patient care and outcomes.

    More Related Videos

    Multidisciplinary Approach to Obesity Management: A Case Report05:10

    Multidisciplinary Approach to Obesity Management: A Case Report

    Published on: May 30, 2025

    470
    Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

    Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

    Published on: August 29, 2025

    173

    Related Concept Videos

    Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

    Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

    Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
    19
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    21
    Obesity01:24

    Obesity

    The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
    705
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    31
    Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

    Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

    Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
    16
    Drug Dosing: Obese Patients01:21

    Drug Dosing: Obese Patients

    In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
    16